BNTC – benitec biopharma inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

BNTC

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/12

12:02 pm

bntc

Benitec Biopharma (NASDAQ:BNTC) had its "buy" rating reaffirmed by analysts at Cowen Inc.

Low Report

Benitec Biopharma (NASDAQ:BNTC) had its "buy" rating reaffirmed by analysts at Cowen Inc.

Report

1/11

08:11 am

bntc

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response [Yahoo! Finance]

Low Report

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response [Yahoo! Finance]

Report

1/11

08:00 am

bntc

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

Low Report

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

Report

12/3

07:02 pm

bntc

Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC) [Yahoo! Finance]

Medium Report

Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC) [Yahoo! Finance]

Report

11/24

08:05 am

bntc

Benitec Biopharma (NASDAQ:BNTC) was given a new $32.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Medium Report

Benitec Biopharma (NASDAQ:BNTC) was given a new $32.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Report

11/18

07:20 am

bntc

Benitec Biopharma (NASDAQ:BNTC) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.

Low Report

Benitec Biopharma (NASDAQ:BNTC) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.

Report

11/18

06:32 am

bntc

Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment [Yahoo! Finance]

Neutral Report

Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment [Yahoo! Finance]

Report

11/18

05:40 am

bntc

Hedge funds investors have a lot riding on Benitec Biopharma Inc. (NASDAQ:BNTC) with 37% ownership [Yahoo! Finance]

Neutral Report

Hedge funds investors have a lot riding on Benitec Biopharma Inc. (NASDAQ:BNTC) with 37% ownership [Yahoo! Finance]

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/14/2025

05:00 pm

bntc

benitec biopharma inc.

BEAT Report

3.1%

benitec biopharma inc.

Report

9/22/2025

04:05 pm

bntc

benitec biopharma inc.

MISS Report

-2.1%

benitec biopharma inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

11/4

07:21 am

Reiterates

Outperform

Citigroup Inc.

Low

Report

2.1%

Report

Date

Time

Symbol

Headline

Impact

12/29

07:31 pm

bntc

Form 4 Benitec Biopharma Inc. For: Dec 23 Filed by: Averill Madison Master Fund, Ltd.

Low Report

Form 4 Benitec Biopharma Inc. For: Dec 23 Filed by: Averill Madison Master Fund, Ltd.

Report

12/22

07:45 pm

bntc

Form 4 Benitec Biopharma Inc. For: Dec 18 Filed by: Averill Madison Master Fund, Ltd.

Low Report

Form 4 Benitec Biopharma Inc. For: Dec 18 Filed by: Averill Madison Master Fund, Ltd.

Report

12/8

11:44 am

bntc

Form SCHEDULE 13G/A Benitec Biopharma Inc. Filed by: JANUS HENDERSON GROUP PLC

Low Report

Form SCHEDULE 13G/A Benitec Biopharma Inc. Filed by: JANUS HENDERSON GROUP PLC

Report

12/3

04:22 pm

bntc

Form SCHEDULE 13G Benitec Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Medium Report

Form SCHEDULE 13G Benitec Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Report

12/3

04:21 pm

bntc

Form 4 Benitec Biopharma Inc. For: Dec 01 Filed by: Mates Sharon

Medium Report

Form 4 Benitec Biopharma Inc. For: Dec 01 Filed by: Mates Sharon

Report

12/3

04:20 pm

bntc

Form 4 Benitec Biopharma Inc. For: Dec 01 Filed by: Mehta Kishan

Medium Report

Form 4 Benitec Biopharma Inc. For: Dec 01 Filed by: Mehta Kishan

Report

12/3

04:18 pm

bntc

Form 4 Benitec Biopharma Inc. For: Dec 01 Filed by: Smith Edward F

Medium Report

Form 4 Benitec Biopharma Inc. For: Dec 01 Filed by: Smith Edward F

Report

12/3

04:17 pm

bntc

Form 4 Benitec Biopharma Inc. For: Dec 01 Filed by: Francis Peter

Medium Report

Form 4 Benitec Biopharma Inc. For: Dec 01 Filed by: Francis Peter

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.